$11.00
-0.06[-0.54%]
At close: May 7
$11.00
0[0.00%]
After Hours: 5:20PM EDT
Pieris Pharmaceuticals
(NASDAQ:PIRS)Pieris Pharmaceuticals Stock (NASDAQ:PIRS), Earnings Estimates, EPS, and Revenue
Pieris Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 21
EPS Estimate
$-0.120
Quarterly Revenue Estimate
$1.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$42.8M
Analyze the earnings history of Pieris Pharmaceuticals using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?
Pieris Pharmaceuticals (PIRS) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Pieris Pharmaceuticals (NASDAQ:PIRS)?
The Actual EPS was $-0.11, which hit the estimate of $-0.11.
What were Pieris Pharmaceuticals’s (NASDAQ:PIRS) revenues?
The Actual Revenue was $19.5M, which beat the estimate of $7.7M.
Browse earnings estimates, EPS, and revenue on all stocks.